Detection of S15 and PD-L1 proteins in more than half of NSCLC samples support the potential to target both pathways during treatment.
Of Interest
Ashfaq Marghoob, MD: Identifying Dermoscopic Patterns in Facial, Palmoplantar, Nail, and Mucosal Lesions
Marghoob shares key dermoscopic features to help clinicians identify benign vs malignant lesions on various locations of the body.
IMA203 Produces Responses in Heavily Pretreated Advanced Melanoma, Other Solid Tumors
The investigational PRAME-targeted T-cell therapy IMA203 generated responses in melanoma and other solid tumors,
RP1 Plus Nivolumab Is Active, Safe in Advanced Melanoma After Progression on Anti–PD-1 Therapy
RP1 plus nivolumab generated responses in advanced melanoma that progressed on or after prior anti–PD-1 therapy.